Malignant fibrous histiocytoma after allogeneic bone marrow transplantation

被引：1

作者：

Vela-Ojeda, J ^{[1
]}

de León, LD ^{[1
]}

Tripp-Villanueva, F ^{[1
]}

Sanchez-Cortés, E ^{[1
]}

Ayala-Sanchez, M ^{[1
]}

Esparza, MAGR ^{[1
]}

Rosas-Cabral, A ^{[1
]}

Gonzalez-Llaven, J ^{[1
]}

机构：

[1] IMSS, Ctr Med Nacl La Raza, Hosp Especialidades, Mexico City 07001, DF, Mexico

来源：

BONE MARROW TRANSPLANTATION | 1999年 / 24卷 / 09期

关键词：

malignant fibrous histiocytoma; bone marrow transplantation; secondary cancer;

D O I：

10.1038/sj.bmt.1701919

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 ;

摘要：

A 24-year-old woman with CML underwent allogeneic BMT in August 1995 from a one-antigen HLA mismatched brother. Conditioning included BuCy2 and CsA and MTX were used to prevent GVHD. In July 1997 she developed right leg pain, lytic bone lesions of distal femur and a solid mass of soft tissue. Histological diagnosis of malignant fibrous histiocytoma was made. Despite treatment with surgery and chemotherapy (doxorubicin and ifosfamide), the patient died 1 year later with local recurrence of the tumor and liver, lung and brain metastases. The CML was in CR.

引用

页码：1029 / 1031

页数：3

共 12 条

[1] Malignant neoplasms following bone marrow transplantation [J].

Bhatia, S ;

Ramsay, NKC ;

Steinbuch, M ;

Dusenbery, KE ;

Shapiro, RS ;

Weisdorf, DJ ;

Robison, LL ;

Miller, JS ;

Neglia, JP .

BLOOD, 1996, 87 (09) :3633-3639

[2] Solid cancers after bone marrow transplantation [J].

Curtis, RE ;

Rowlings, PA ;

Deeg, HJ ;

Shriner, DA ;

Socie, G ;

Travis, LB ;

Horowitz, MM ;

Witherspoon, RP ;

Hoover, RN ;

Sobocinski, KA ;

Fraumeni, JF ;

Boice, JD .

NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (13) :897-904

[3] RISK-FACTORS FOR THE DEVELOPMENT OF SECONDARY MALIGNANCIES AFTER MARROW TRANSPLANTATION [J].

DEEG, HJ ;

WITHERSPOON, RP .

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1993, 7 (02) :417-429

[4] Malignancies after marrow transplantation for aplastic anemia and Fanconi anemia: A joint Seattle and Paris analysis of results in 700 patients [J].

Deeg, HJ ;

Socie, G ;

Schoch, G ;

HenryAmar, M ;

Witherspoon, RP ;

Devergie, A ;

Sullivan, KM ;

Gluckman, E ;

Storb, R .

BLOOD, 1996, 87 (01) :386-392

[5]

GUSTAFSON P, 1994, ACTA ORTHOP SCAND, V65, P1

[6]

IORI AP, 1994, BONE MARROW TRANSPL, V14, P492

[7]

PESCE A, 1993, TRANSPLANT P, V25, P2299

[8] THE BIOLOGY OF ALKYLATING-AGENT CELLULAR INJURY [J].

SHULMAN, LN .

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1993, 7 (02) :325-335

[9] BONE SARCOMAS LINKED TO RADIOTHERAPY AND CHEMOTHERAPY IN CHILDREN [J].

TUCKER, MA ;

DANGIO, GJ ;

BOICE, JD ;

STRONG, LC ;

LI, FP ;

STOVALL, M ;

STONE, BJ ;

GREEN, DM ;

LOMBARDI, F ;

NEWTON, W ;

HOOVER, RN ;

FRAUMENI, JF .

NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (10) :588-593

[10]

WIKLUND TA, 1991, CANCER, V68, P524, DOI 10.1002/1097-0142(19910801)68:3<524::AID-CNCR2820680313>3.0.CO

← 1 2 →